Found: 13
Select item for more details and to access through your institution.
Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid Tumours.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Outcomes of Patients with Metastatic Melanoma Treated with Molecularly Targeted Agents in Phase I Clinical Trials.
- Published in:
- Oncology, 2011, v. 81, n. 2, p. 135, doi. 10.1159/000330206
- By:
- Publication type:
- Article
Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0047020
- By:
- Publication type:
- Article
Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor.
- Published in:
- Journal of Pathology, 2013, v. 229, n. 3, p. 422, doi. 10.1002/path.4140
- By:
- Publication type:
- Article
Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1807, doi. 10.1111/bcp.14283
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Olaparib tablet formulation: effect of food on the pharmacokinetics after oral dosing in patients with advanced solid tumours.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1213, doi. 10.1007/s00280-013-2286-7
- By:
- Publication type:
- Article
A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI<sup>™</sup>), in patients with advanced solid tumours.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 425, doi. 10.1007/s00280-009-0968-y
- By:
- Publication type:
- Article
Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors.
- Published in:
- Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 3, doi. 10.1186/1756-8722-7-1
- By:
- Publication type:
- Article
Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase I study of intravenous and oral rucaparib in combination with chemotherapy in patients with advanced solid tumours.
- Published in:
- 2017
- By:
- Publication type:
- journal article